Day
|
Date
|
'
|
Time
|
Icon
|
Event
|
Chair
|
Scribe
|
Room
|
Monday
|
Sep 23
|
AM
|
Q1
|
|
No Meeting
|
|
|
|
|
|
Q2
|
|
No Meeting
|
|
|
|
|
PM
|
Q3
|
|
OO
- Project Administrivia
- V2.8.1 Ballot Reconciliation
|
Available Chairs: Hans, Ken, Lorraine, Patrick
|
|
|
|
|
Q4
|
|
OO
|
Available Chairs: Hans, Patrick, Ken, Lorraine
|
|
|
. |
|
|
|
|
|
|
|
|
Tuesday
|
Sep 24
|
AM
|
Q1
|
|
OO
|
Available Chairs: Lorraine, Ken
|
|
|
|
|
Q2
|
|
OO/Rx + Pt Safety + RCRIM + PHER
- Substance CMET disposition in light of CPM
|
Available Chairs: Ken, Lorraine
|
|
|
|
PM
|
Q3
|
|
OO/PHER
- ELR Ballot Reconciliation
|
Available Chairs: Hans, Ken, (Rob)
|
|
|
|
|
Q4
|
|
OO
- UDI - Leslie Tompkins, Terrie Reed (FDA)
- eDOS Ballot Reconciliation
|
Available Chairs: Hans, Ken, Rob, (Lorraine)
|
|
|
. |
|
|
|
|
|
|
|
|
Wednesday
|
May 8
|
AM
|
Q1
|
|
OO/II/AP/CG
- CG - Biomarkers Initiative Report
- Specimen
|
Available Chairs: Lorraine, Ken, Patrick
|
|
|
|
|
Q2
|
|
OO/FHIR
- FHIR Ballot Reconciliation
|
Available Chairs: Lorraine, Hans, Patrick, Ken, (Rob)
|
|
|
|
PM
|
Q3
|
|
OO
- LOI Ballot Reconciliation
|
Available Chairs: Hans, Lorraine, Rob, Ken
|
|
|
|
|
Q4
|
|
OO / SAIF AP
- First half of quarter
- joint with SAIF AP re Lessons Learned on alpha project
- Second Half of quarter
- V2.8.1 Ballot Reconciliation or eDOS Ballot Reconciliation
|
Available Chairs: Hans, Lorraine, Ken, (Rob)
|
|
|
. |
|
|
|
|
|
|
|
|
Thursday
|
Sep 26
|
AM
|
Q1
|
|
OO/Clincial Decision Support + Pt Care
- Order Service
- vMR Logical Model
- Templates
- Allergy Update
|
Available Chairs: Hans, Lorraine,
|
|
|
|
|
Q2
|
|
OO/FHIR
- FHIR Ballot Reconciliation
- FHIR Planning
|
Available Chairs: Hans, Lorraine,
|
|
|
|
PM
|
Q3
|
|
CS/OO
|
Available Chairs: Rik, Hans, Patrick
|
|
|
|
|
Q4
|
|
OO
- LOI or eDOS Ballot Reconciliation
|
Available Chairs: Hans, Ken
|
|
|
. |
|
|
|
|
|
|
|
|
Friday
|
Sep 27
|
AM
|
Q1
|
|
OO
- V2.8.1 / ELR / eDOS / LOI Ballot Reconciliation
|
Available Chairs: Hans, Ken,
|
|
|
|
|
Q2
|
|
|
|
|
|
|
PM
|
Q3
|
|
No Meeting
|
|
|
|
|
|
Q4
|
|
No Meeting
|
|
|
|